Heart Test Laboratories Inc (HSCS)

$3.24 -0.13 (-3.86%)
Market Cap 2.27M
Revenue (ttm) 20,000.00
Net Income (ttm) -6.61M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 11,938
Avg Vol 455,542
Day's Range N/A - N/A
Shares Out 656,000.00
Stochastic %K 24%
Beta 3.16
Analysts Strong Sell
Price Target $13.50

Company Profile

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventi...

Industry: Medical Devices
Sector: Healthcare
Phone: 682 237 7781
Address:
550 Reserve Street, Suite 360, Southlake, United States
NetworkNewsWire
NetworkNewsWire Feb. 23 at 6:27 PM
BioMedNewsBreaks — $HSCS $HSCSW Secures UWE As Exclusive ECG Education Reference Center https://ibn.fm/fkzAO
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 3:16 PM
$HSCS Current Stock Price: $2.84
0 · Reply
Moneyybaggs
Moneyybaggs Feb. 23 at 2:45 PM
$HSCS DT! Take out that ask of 17,400 shares at $2.95 and let’s get HSCS moving up and to the right!!! LFGOOOOOOOOOO HSCS!!!
1 · Reply
topstockalerts
topstockalerts Feb. 23 at 2:28 PM
$HSCS here it comes…
0 · Reply
EmproX
EmproX Feb. 23 at 12:28 PM
$FTRK $LEGN $VGAS $HSCS <>
0 · Reply
DrTampa
DrTampa Feb. 20 at 8:04 PM
$HSCS Price drops allow for more acculumlation! I'm now just shy of 143,000 as of today, and will keep accumulating until I'm just shy of 5%! Who knows, maybe I'll go crazy and buy more than 5% and file that 13G form lol
0 · Reply
Moneyybaggs
Moneyybaggs Feb. 19 at 3:49 PM
$HSCS That’s the $1M conundrum!!! Simpson says the MyoVista Insights platform is the greatest thing since sliced bread but if nobody adopts the technology then it doesn’t matter. Clearly the market doesn’t believe it’s gonna happen. HSCS has a MC of $10.5M. RUFKM?!? Why hasn’t a big fish swooped in and bought these guys for $50-100M?!? Endorsements are NOTHING BURGERS. Simpson needs to announce a commercial contract with a big player that generates serious revenue and this stock is over $30 per share instantly. Currently he doesn’t have that player in the barn. We’re betting he lands that player in the barn.
2 · Reply
14745Barclay
14745Barclay Feb. 19 at 1:23 PM
$HSCS Part of me are excited this company finally is able to gain some tractions with recent announcement of FDA submission and uptake of some institutions of the Myovista platform. However, part of me is very nervous for them about commercialization. If they can not sell, how is the company going to generate any positive cash flow? Any thoughts?
1 · Reply
MaryMiceli912
MaryMiceli912 Feb. 18 at 1:58 PM
$HSCS Healthcare services microcap with execution risk.
0 · Reply
DrTampa
DrTampa Feb. 17 at 10:19 PM
$HSCS crossed over 140,000 shares today 🤑🤑🤑 Drop the FDA news! Drop the myo Vista insights contract news!
0 · Reply
Latest News on HSCS
University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Feb 5, 2026, 8:30 AM EST - 18 days ago

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Jan 29, 2026, 8:30 AM EST - 25 days ago

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Dec 15, 2025, 4:15 PM EST - 2 months ago

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Dec 15, 2025, 8:30 AM EST - 2 months ago

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Dec 11, 2025, 8:30 AM EST - 2 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Sep 11, 2025, 4:15 PM EDT - 5 months ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

HeartSciences Announces Conference Participation and Investor Webinar

Aug 15, 2025, 9:00 AM EDT - 6 months ago

HeartSciences Announces Conference Participation and Investor Webinar

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Jul 24, 2025, 4:15 PM EDT - 7 months ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Jun 4, 2025, 9:00 AM EDT - 9 months ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

Jun 3, 2025, 9:00 AM EDT - 9 months ago

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 29, 2025, 9:00 AM EDT - 9 months ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 20, 2025, 9:00 AM EDT - 9 months ago

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

May 8, 2025, 9:00 AM EDT - 10 months ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

May 7, 2025, 9:00 AM EDT - 10 months ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

May 1, 2025, 9:00 AM EDT - 10 months ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 13, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Mar 10, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Dec 16, 2024, 4:15 PM EST - 1 year ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Nov 13, 2024, 9:00 AM EST - 1 year ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 14, 2024, 4:15 PM EDT - 1 year ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Sep 12, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 29, 2024, 4:05 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 25, 2024, 8:30 AM EDT - 1 year ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jul 11, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Jun 4, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

May 20, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 24, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

HeartSciences to Present at the LD Micro Invitational XIV Conference

Apr 2, 2024, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 26, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 14, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Mar 6, 2024, 9:00 AM EST - 2 years ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 26, 2024, 9:00 AM EST - 2 years ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

HeartSciences Expands its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 2 years ago

HeartSciences Expands its Scientific Advisory Board

HeartSciences Appoints New Scientific Advisory Board Member

Feb 1, 2024, 9:00 AM EST - 2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Jan 18, 2024, 8:00 AM EST - 2 years ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Jan 3, 2024, 4:15 PM EST - 2 years ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Dec 14, 2023, 4:15 PM EST - 2 years ago

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Dec 5, 2023, 8:00 AM EST - 2 years ago

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Nov 13, 2023, 8:45 AM EST - 2 years ago

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT SINT

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Sep 14, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

Sep 11, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

Sep 7, 2023, 9:00 AM EDT - 2 years ago

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

Aug 31, 2023, 9:00 AM EDT - 2 years ago

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

HeartSciences' MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

Aug 24, 2023, 9:00 AM EDT - 2 years ago

HeartSciences' MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio

Aug 17, 2023, 9:00 AM EDT - 2 years ago

HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio

NetworkNewsWire
NetworkNewsWire Feb. 23 at 6:27 PM
BioMedNewsBreaks — $HSCS $HSCSW Secures UWE As Exclusive ECG Education Reference Center https://ibn.fm/fkzAO
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 3:16 PM
$HSCS Current Stock Price: $2.84
0 · Reply
Moneyybaggs
Moneyybaggs Feb. 23 at 2:45 PM
$HSCS DT! Take out that ask of 17,400 shares at $2.95 and let’s get HSCS moving up and to the right!!! LFGOOOOOOOOOO HSCS!!!
1 · Reply
topstockalerts
topstockalerts Feb. 23 at 2:28 PM
$HSCS here it comes…
0 · Reply
EmproX
EmproX Feb. 23 at 12:28 PM
$FTRK $LEGN $VGAS $HSCS <>
0 · Reply
DrTampa
DrTampa Feb. 20 at 8:04 PM
$HSCS Price drops allow for more acculumlation! I'm now just shy of 143,000 as of today, and will keep accumulating until I'm just shy of 5%! Who knows, maybe I'll go crazy and buy more than 5% and file that 13G form lol
0 · Reply
Moneyybaggs
Moneyybaggs Feb. 19 at 3:49 PM
$HSCS That’s the $1M conundrum!!! Simpson says the MyoVista Insights platform is the greatest thing since sliced bread but if nobody adopts the technology then it doesn’t matter. Clearly the market doesn’t believe it’s gonna happen. HSCS has a MC of $10.5M. RUFKM?!? Why hasn’t a big fish swooped in and bought these guys for $50-100M?!? Endorsements are NOTHING BURGERS. Simpson needs to announce a commercial contract with a big player that generates serious revenue and this stock is over $30 per share instantly. Currently he doesn’t have that player in the barn. We’re betting he lands that player in the barn.
2 · Reply
14745Barclay
14745Barclay Feb. 19 at 1:23 PM
$HSCS Part of me are excited this company finally is able to gain some tractions with recent announcement of FDA submission and uptake of some institutions of the Myovista platform. However, part of me is very nervous for them about commercialization. If they can not sell, how is the company going to generate any positive cash flow? Any thoughts?
1 · Reply
MaryMiceli912
MaryMiceli912 Feb. 18 at 1:58 PM
$HSCS Healthcare services microcap with execution risk.
0 · Reply
DrTampa
DrTampa Feb. 17 at 10:19 PM
$HSCS crossed over 140,000 shares today 🤑🤑🤑 Drop the FDA news! Drop the myo Vista insights contract news!
0 · Reply
Moneyybaggs
Moneyybaggs Feb. 13 at 3:36 PM
$HSCS NOBODY gives two shits about our little baby. A whopping 215 shares traded the first hour. FMTT!!!
1 · Reply
Moneyybaggs
Moneyybaggs Feb. 12 at 7:29 PM
$HSCS Just 6K shares have filled. Very few shares are for sale otherwise that 22K shares in the bid would have been filled. Again, VERY LITTLE stock for sale!!! Light the fuse on the powder keg Simpson!!!
0 · Reply
DrTampa
DrTampa Feb. 12 at 7:21 PM
$HSCS looks like that 20,000 share buy order at $3.10 has been slowly filling all day!
0 · Reply
Moneyybaggs
Moneyybaggs Feb. 11 at 6:08 PM
$HSCS DT, I think that’s your 20.3K share bid @ $3.10!!!
1 · Reply
DrTampa
DrTampa Feb. 11 at 4:41 PM
$HSCS someone really trying to buy some shares 👀👀
0 · Reply
Moneyybaggs
Moneyybaggs Feb. 11 at 4:38 PM
$HSCS It will be interesting to see if any seller hits that bid of 20,300 shares @ $3.10. That mega bid has been there for several days.
1 · Reply
Moneyybaggs
Moneyybaggs Feb. 11 at 3:48 PM
$HSCS Has HSCS been halted?!? 🧐 WTF?!? Light the fuse Simpson and send this stock skyward!!!
1 · Reply
DrTampa
DrTampa Feb. 10 at 8:40 PM
$HSCS almost up to 140,000 shares 🤑🤑🤑 drop the revenue news Simpson!
1 · Reply
DrTampa
DrTampa Feb. 9 at 6:48 PM
$HSCS on such a low volume day, when I place an order for a hundred shares at market price and then tons of other orders come in at the same time...strange...
0 · Reply
TrendSnatch
TrendSnatch Feb. 9 at 11:25 AM
$HSCS is a healthcare software or services company; integrating with legacy hospital IT systems is complex and costly, slowing deployment cycles and time to revenue recognition.
0 · Reply
char13
char13 Feb. 9 at 10:39 AM
$HSCS people are moving this
0 · Reply
Moneyybaggs
Moneyybaggs Feb. 8 at 11:27 AM
$HSCS Possibly FDA approval this week? It’s been 2 months since submission. If I remember correctly I think the FDA has 90 days to respond. Is that correct @DrTampa? Keep rolling out those Myovista Insight customer deployment announcements Simpson. Time to fly!!!
1 · Reply